Clinical Programs
- In 2004, the Yale Adult Congenital Heart Program was initiated as the first integrated program in the State of Connecticut dedicated to the care of adult patients with congenital heart disease.
- This unique program is an internationally recognized center for inherited cardiomyopathy.
The Yale Echo Laboratory uses state-of-the-art equipment capable of 2D and 3D imaging, intracavitary contrast, and strain imaging.
Comprehensive Care for Cardiac Arrhythmias
Our electrophysiology team provides comprehensive care for patients with cardiac arrhythmias using the latest diagnostic and cutting-edge therapeutic tools.- The Cardiovascular Genetics Program at Yale School of Medicine, directed by Arya Mani, MD, was established in 2010 to provide care for patients and families who are suspected of having inherited cardiovascular disease.
Directed by Daniel Jacoby, MD, in collaboration with Arnar Geirsson, MD, the Advanced Heart Failure Program provides a comprehensive, multi-disciplinary approach to caring for patients with end-stage heart failure.
- The Yale Cardiovascular Medicine Imaging program is a world-leading, multidisciplinary program focused on state-of-the-art patient care, education, and research.
Inpatient cardiovascular services encompass CCU and the step down unit, the Goodyer service (general inpatient cardiology) and the consult service.
- The Interventional Cardiology service provides state of the art facilities for a full spectrum of coronary, structural heart, and peripheral vascular interventions (PVI).
- Research has shown that the expression of negative emotions in response to a real or perceived provocation seems to consistently correlate with acute cardiac events.
- The Nuclear Cardiac Imaging program at Yale is a high-volume lab (more than 4000 SPECT, PET and gated blood pool studies per year) that employs state-of-the-art technology to provide critical diagnostic and prognostic information. Our lab performs both inpatient and outpatient stress testing, optimizing the stress protocol and imaging protocol for each patient.
- One of the very few of its kind, the cardio-oncology program provides dedicated expertise in evaluation and management of cardiac dysfunction in patients receiving a variety anti-tumor therapies and also provides pre-therapy cardiac risk assessment and comprehensive cardiac care for cancer patients with coexisting heart disease. The program is integrated into activities of the Smilow Cancer Hospital to make access easier for patients.
- Under the leadership of Daniel Price, MD, Yale Cardiovascular Medicine offers a full range of cardiology services in the ambulatory setting at locations throughout Southern ConnecticutUnder the leadership of Daniel Price, MD,. Through the Yale New Haven Heart and Vascular Center, services are provided by Yale faculty physicians in easily accessible and patient-friendly facilities. These sites provide not only consultative services but also comprehensive non-invasive diagnostic testing.
- Yale has a long tradition of being at the forefront of interventional innovation, currently we are heavily involved in different clinical trials including iliac and SFA stent intervention, drug – eluting angioplasty balloons, carotid stenting, and renal denervation therapy. Our advanced vascular medicine and endovascular interventional training pathway provides comprehensive training for physicians to pursue an independently funded academic career in vascular medicine.
In 2004, the Yale Adult Congenital Heart Program was initiated as the first integrated program in the State of Connecticut dedicated to the care of adult patients with congenital heart disease.
This unique program is an internationally recognized center for inherited cardiomyopathy.
The Yale Echo Laboratory uses state-of-the-art equipment capable of 2D and 3D imaging, intracavitary contrast, and strain imaging.
Our electrophysiology team provides comprehensive care for patients with cardiac arrhythmias using the latest diagnostic and cutting-edge therapeutic tools.
The Cardiovascular Genetics Program at Yale School of Medicine, directed by Arya Mani, MD, was established in 2010 to provide care for patients and families who are suspected of having inherited cardiovascular disease.
Directed by Daniel Jacoby, MD, in collaboration with Arnar Geirsson, MD, the Advanced Heart Failure Program provides a comprehensive, multi-disciplinary approach to caring for patients with end-stage heart failure.
The Yale Cardiovascular Medicine Imaging program is a world-leading, multidisciplinary program focused on state-of-the-art patient care, education, and research.
Inpatient cardiovascular services encompass CCU and the step down unit, the Goodyer service (general inpatient cardiology) and the consult service.
The Interventional Cardiology service provides state of the art facilities for a full spectrum of coronary, structural heart, and peripheral vascular interventions (PVI).
Research has shown that the expression of negative emotions in response to a real or perceived provocation seems to consistently correlate with acute cardiac events.
The Nuclear Cardiac Imaging program at Yale is a high-volume lab (more than 4000 SPECT, PET and gated blood pool studies per year) that employs state-of-the-art technology to provide critical diagnostic and prognostic information. Our lab performs both inpatient and outpatient stress testing, optimizing the stress protocol and imaging protocol for each patient.
One of the very few of its kind, the cardio-oncology program provides dedicated expertise in evaluation and management of cardiac dysfunction in patients receiving a variety anti-tumor therapies and also provides pre-therapy cardiac risk assessment and comprehensive cardiac care for cancer patients with coexisting heart disease. The program is integrated into activities of the Smilow Cancer Hospital to make access easier for patients.
Under the leadership of Daniel Price, MD, Yale Cardiovascular Medicine offers a full range of cardiology services in the ambulatory setting at locations throughout Southern ConnecticutUnder the leadership of Daniel Price, MD,. Through the Yale New Haven Heart and Vascular Center, services are provided by Yale faculty physicians in easily accessible and patient-friendly facilities. These sites provide not only consultative services but also comprehensive non-invasive diagnostic testing.
Yale has a long tradition of being at the forefront of interventional innovation, currently we are heavily involved in different clinical trials including iliac and SFA stent intervention, drug – eluting angioplasty balloons, carotid stenting, and renal denervation therapy. Our advanced vascular medicine and endovascular interventional training pathway provides comprehensive training for physicians to pursue an independently funded academic career in vascular medicine.